Roberto C. Goizueta was chairman and CEO of The Coca-Cola Company from 1981 until 1997. Mr. Goizueta's relationship with Emory began in 1980, when he was named to the Emory University Board of Trustees. He contributed substantially to the progress of Emory and the business school, which bears his name. Mr. Goizueta was diagnosed him with lung cancer in September 1997, and he died at Emory University Hospital on October 18, 1997 at the age of 65.
Through memorial contributions, Emory later established the Roberto C. Goizueta Chair for Cancer Research, designated for a key leader in Winship's Lung Cancer Program. Inaugurated in 2007, the Goizueta Chair was awarded to Fadlo Khuri, MD, Winship's then Deputy Director and the first Chairman of Emory's Department of Hematology and Medical Oncology. Today, Suresh Ramalingam, MD, holds the Goizueta Chair as Winship's Deputy Director and Director of the Winship Lung Cancer Program.
Throughout his life, Mr. Goizueta was driven by curiosity, intellectual courage, and integrity, attributes deeply shared by those on the frontlines of lung cancer research who have been supported through Mr. Goizueta's legacy.
Suresh S. Ramalingam, MD, deputy director of Winship Cancer Institute of Emory University, was honored with the Roberto C. Goizueta Distinguished Chair for Cancer Research in 2016.